LOSS OF 5-HYDROXYMETHYLCYTOSINE AS A BIOMARKER FOR CANCER
    1.
    发明申请
    LOSS OF 5-HYDROXYMETHYLCYTOSINE AS A BIOMARKER FOR CANCER 审中-公开
    作为癌症生物标记的5-羟基甲基吗啉的损失

    公开(公告)号:US20140030727A1

    公开(公告)日:2014-01-30

    申请号:US13747306

    申请日:2013-01-22

    IPC分类号: G01N33/574 G01N33/483

    CPC分类号: G01N33/57496 G01N33/4833

    摘要: Methods for detecting or diagnosing cancer in a subject are provided herein. Such methods may include, but are not limited to, measuring a test level of 5hmC in a biological sample from the subject; and determining that the subject has a malignant cancer when the test level of 5hmC is lower than that of a control level of 5hmC. Such methods may further include a step of measuring a test level of Ki67 in the biological sample and determining that the subject has a malignant cancer when the test level of Ki67 is higher than that of a control level of Ki67.

    摘要翻译: 本文提供了用于检测或诊断受试者中的癌症的方法。 这样的方法可以包括但不限于测量来自受试者的生物样品中的5hmC的测试水平; 并且当5hmC的测试水平低于5hmC的对照水平时,确定受试者具有恶性癌症。 这样的方法还可以包括当Ki67的检测水平高于对照水平的Ki67时,测量生物样品中Ki67的测试水平并确定受试者具有恶性癌症的步骤。

    Method for detecting methylated CpG islands
    3.
    发明申请
    Method for detecting methylated CpG islands 有权
    检测甲基化CpG岛的方法

    公开(公告)号:US20060240460A1

    公开(公告)日:2006-10-26

    申请号:US11398765

    申请日:2006-04-06

    IPC分类号: C12Q1/68 C12P19/34

    CPC分类号: C12Q1/6813 C12Q2537/164

    摘要: The present invention provides new and improved assay for detection of genomic methylated CpG islands. This new method is termed the methylated-CpG island recovery assay (MIRA). In accordance with one embodiment, MIRA comprises the steps of: (a) incubating genomic DNA fragments with a methylated CpG island binding protein in the presence of a binding partner for the binding protein to produce bound DNA containing methylated CpG islands, (b) isolating the bound DNA, and (c) detecting CpG island methylation by gene-specific amplification reactions. In accordance with a preferred embodiment, MIRA comprises the steps of: (a) incubating sonicated genomic DNA with a matrix containing a fusion protein of glutathione S-transferase (GST) and MBD2b (GST-MBD2b) in the presence of MBD3L1 to produce bound DNA containing methylated CpG islands, (b) eluting bound DNA from the matrix, and (c) detecting CpG island methylation by gene-specific amplification reactions.

    摘要翻译: 本发明提供用于检测基因组甲基化CpG岛的新的和改进的测定。 这种新方法被称为甲基化CpG岛回收测定(MIRA)。 根据一个实施方案,MIRA包括以下步骤:(a)在结合蛋白的结合配偶体存在下,将基因组DNA片段与甲基化CpG岛结合蛋白质孵育以产生含有甲基化CpG岛的结合DNA,(b)分离 结合DNA,和(c)通过基因特异性扩增反应检测CpG岛甲基化。 根据优选实施方案,MIRA包括以下步骤:(a)在MBD3L1存在下,将超声处理的基因组DNA与含有谷胱甘肽S-转移酶(GST)和MBD2b(GST-MBD2b)的融合蛋白的基质一起温育以产生结合 含有甲基化CpG岛的DNA,(b)从基质中洗脱结合的DNA,和(c)通过基因特异性扩增反应检测CpG岛甲基化。